201 related articles for article (PubMed ID: 9060679)
21. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
Quivy V; Adam E; Collette Y; Demonte D; Chariot A; Vanhulle C; Berkhout B; Castellano R; de Launoit Y; Burny A; Piette J; Bours V; Van Lint C
J Virol; 2002 Nov; 76(21):11091-103. PubMed ID: 12368351
[TBL] [Abstract][Full Text] [Related]
22. Hiv-1 Tat can substantially enhance the capacity of NIK to induce IkappaB degradation.
Li X; Josef J; Marasco WA
Biochem Biophys Res Commun; 2001 Aug; 286(3):587-94. PubMed ID: 11511100
[TBL] [Abstract][Full Text] [Related]
23. Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells.
Hirano F; Chung M; Tanaka H; Maruyama N; Makino I; Moore DD; Scheidereit C
Mol Cell Biol; 1998 May; 18(5):2596-607. PubMed ID: 9566879
[TBL] [Abstract][Full Text] [Related]
24. Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor IkappaB alpha.
Roth J; Dobbelstein M
J Virol; 1997 Nov; 71(11):8933-9. PubMed ID: 9343262
[TBL] [Abstract][Full Text] [Related]
25. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.
Duan L; Zhang H; Oakes JW; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1994 Nov; 5(11):1315-24. PubMed ID: 7893803
[TBL] [Abstract][Full Text] [Related]
26. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.
Malim MH; Freimuth WW; Liu J; Boyle TJ; Lyerly HK; Cullen BR; Nabel GJ
J Exp Med; 1992 Oct; 176(4):1197-201. PubMed ID: 1402661
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha.
Kabouridis PS; Hasan M; Newson J; Gilroy DW; Lawrence T
J Immunol; 2002 Sep; 169(5):2587-93. PubMed ID: 12193729
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
[TBL] [Abstract][Full Text] [Related]
29. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional insights into IκB-α/HIV-1 Tat interaction.
Vitagliano L; Fiume G; Scognamiglio PL; Doti N; Cannavò R; Puca A; Pedone C; Scala G; Quinto I; Marasco D
Biochimie; 2011 Sep; 93(9):1592-600. PubMed ID: 21664225
[TBL] [Abstract][Full Text] [Related]
31. [Recent progress in the study of HIV-1 transcription factor NF-kappaB and its inhibitors].
Yu MY; Liu XY
Yao Xue Xue Bao; 2007 Oct; 42(10):1007-12. PubMed ID: 18229603
[TBL] [Abstract][Full Text] [Related]
32. Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.
Coiras M; López-Huertas MR; Rullas J; Mittelbrunn M; Alcamí J
Retrovirology; 2007 Aug; 4():56. PubMed ID: 17686171
[TBL] [Abstract][Full Text] [Related]
33. BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function.
Morrison TE; Kenney SC
Virology; 2004 Oct; 328(2):219-32. PubMed ID: 15464842
[TBL] [Abstract][Full Text] [Related]
34. Dopamine stimulates expression of the human immunodeficiency virus type 1 via NF-kappaB in cells of the immune system.
Rohr O; Sawaya BE; Lecestre D; Aunis D; Schaeffer E
Nucleic Acids Res; 1999 Aug; 27(16):3291-9. PubMed ID: 10454636
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human immunodeficiency virus type 1 replication is enhanced by a combination of transdominant Tat and Rev proteins.
Ulich C; Harrich D; Estes P; Gaynor RB
J Virol; 1996 Jul; 70(7):4871-6. PubMed ID: 8676525
[TBL] [Abstract][Full Text] [Related]
36. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
[TBL] [Abstract][Full Text] [Related]
37. Evolution of the human immunodeficiency virus type 1 long terminal repeat promoter by conversion of an NF-kappaB enhancer element into a GABP binding site.
Verhoef K; Sanders RW; Fontaine V; Kitajima S; Berkhout B
J Virol; 1999 Feb; 73(2):1331-40. PubMed ID: 9882338
[TBL] [Abstract][Full Text] [Related]
38. NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases.
Bossis G; Salinas S; Cartier C; Devaux C; Briant L
FEBS Lett; 2002 Apr; 516(1-3):257-64. PubMed ID: 11959143
[TBL] [Abstract][Full Text] [Related]
39. NF-kappaB protects HIV-1-infected myeloid cells from apoptosis.
DeLuca C; Kwon H; Pelletier N; Wainberg MA; Hiscott J
Virology; 1998 Apr; 244(1):27-38. PubMed ID: 9581775
[TBL] [Abstract][Full Text] [Related]
40. The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.
Ganesh L; Burstein E; Guha-Niyogi A; Louder MK; Mascola JR; Klomp LW; Wijmenga C; Duckett CS; Nabel GJ
Nature; 2003 Dec; 426(6968):853-7. PubMed ID: 14685242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
